Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: So PENDING is the key term EOM

TPL are representatives for MMP and one other non-MMP patent portfolio in this case (the name escapes me). It would still be correct to refer to these "cases" (plural) as "pending" would it not?

It certainly still fits with a contingency theory but I don't think this latest pacer confirms it without a doubt. JMO

Share
New Message
Please login to post a reply